Related Experiment Video

Updated: Mar 17, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.1K

Expression of microRNA miR-34a inhibits leukemia stem cells and its metastasis

S Wang1, T Wang, M-Z Li

  • 1Department of Neonatal Medicine, Wuhan Medical $ Health Care Center for Women and Children (Wuhan Children's Hospital Wuhan Women and Children Care Hospital), Wuhan, China. lixiaolan1978@yahoo.com.

European Review for Medical and Pharmacological Sciences
|July 19, 2016
PubMed
Abstract

Insights

MicroRNA miR-34a, when expressed in acute myeloid leukemia stem cells (LSC), inhibits their growth and metastasis. This finding positions miR-34a as a potential therapeutic agent for leukemia.

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • Leukemia stem cells (LSC) drive acute myeloid leukemia (AML) progression and metastasis.
  • MicroRNAs play crucial roles in cancer development and regulation.
  • The specific role of miR-34a in LSC and metastasis requires further elucidation.

Purpose of the Study:

  • To investigate the expression profile and functional role of microRNA miR-34a in leukemia stem cells (LSC).
  • To determine the impact of enforced miR-34a expression on LSC and their metastatic potential.

Main Methods:

  • Samples from pediatric acute myeloid leukemia (AML) patients and controls were analyzed.
  • Immunohistochemistry and flow cytometry were used to identify TIM3 positive LSC.
  • Quantitative real-time PCR (qRT-PCR) was employed to measure miR-34a expression levels.

Main Results:

  • TIM3 positive LSC were identified in AML samples.
  • Induced expression of miR-34a in TIM3 positive LSC significantly inhibited clonogenic expansion.
  • Enforced miR-34a expression suppressed tumor progression and metastasis of leukemia.

Conclusions:

  • Enforced expression of miR-34a in TIM3 positive LSC effectively inhibits leukemia stem cell proliferation and metastasis.
  • miR-34a acts as a key regulator in leukemia.
  • miR-34a holds promise as a novel therapeutic target for combating leukemia stem cells.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.8K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K